APA (7th ed.) Citation

Doiron, R. C., Nickel, J. C., & Kamdar, S. (2026). The sublingual vaccine MV140 is dominant over prophylactic antibiotics for the prevention of recurrent, uncomplicated urinary tract infections in adult women A cost-utility analysis. Canadian Urological Association Journal, 20(5), 54. https://doi.org/10.5489/cuaj.9237

Chicago Style (17th ed.) Citation

Doiron, R. Christopher, J. Curtis Nickel, and Shivani Kamdar. "The Sublingual Vaccine MV140 Is Dominant over Prophylactic Antibiotics for the Prevention of Recurrent, Uncomplicated Urinary Tract Infections in Adult Women A Cost-utility Analysis." Canadian Urological Association Journal 20, no. 5 (2026): 54. https://doi.org/10.5489/cuaj.9237.

MLA (9th ed.) Citation

Doiron, R. Christopher, et al. "The Sublingual Vaccine MV140 Is Dominant over Prophylactic Antibiotics for the Prevention of Recurrent, Uncomplicated Urinary Tract Infections in Adult Women A Cost-utility Analysis." Canadian Urological Association Journal, vol. 20, no. 5, 2026, p. 54, https://doi.org/10.5489/cuaj.9237.